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Regarding “Long-term results of stent graft
treatment of subclavian artery injuries: Management
of choice for stable patients?”
We read with interest the article regarding stent graft treat-
ment of 57 traumatic sublcavian arterial injuries.1 It is surprising
that no mention was made of the vertebral artery. Certainly with
stent grafts varying from 30 to 60 mm in length, the vertebral
artery was covered in many (if not most) of their cases. If this is
true, did they first determine if the contralateral vertebral artery
was patent all the way to the basilar artery? After all, a hypoplastic
vertebral artery is an uncommon, but real, entity. The authors
reported that they treated 39% of their subclavian injuries with
stent grafts and believe that up to 50% of such injuries could be
treated in this fashion. Does proximity of the subclavian injury to
the vertebral artery origin play a role in the 50% who cannot be
treated endovascularly?
Also of interest is the statement that a stent graft cannot be
used if there is much of a difference in arterial diameters at the
proximal and distal landing zones. Except for their 12 cases of
arteriovenous fistulae, the diameter of a subclavian artery should
not change much from proximal to distal. Even if it did, Fluency
stent grafts (Bard, Tempe, Arizona) have been shown to have
minimal infolding when oversized up to 3 mm relative to the
vessel. How often would proximal to distal subclavian diameter
ever be a problem?
Overall, we found this series of 57 subclavian arterial injuries
treated endovascularly without limb loss or other incapacitating
symptoms to be impressive. However, we would like to have seen
a discussion of the vertebral artery and believe that proximal and
distal luminal discrepancy of the subclavian artery would be a rare
contraindication to stent graft placement.
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We appreciate the interest of Drs Smith and Carlson in our
article reporting the long-term results of stent graft treatment of
subclavian artery injuries.1 We thank them for the 2 interesting
comments. We did not describe all the technical details of the
procedure but did refer to our previously published article2 where
the issue of the vertebral artery was discussed. We did cover the
vertebral artery in many of the cases after confirming by angiogra-
phy that a patent normal sized contra lateral vertebral artery with
good cross flow into the Circle of Willis was present. No neuro-
logical complications were encountered as a result of this approach.
Although the reported incidence of congenital atresia or hypopla-
sia of one vertebral artery is 2%-3%,3 we did not exclude any patient
from endovascular treatment on the basis of this finding. We agree
that it might be a rare contraindication to stent graft treatment if
encountered on the contra lateral side to the injury.
We agree that luminal discrepancy is a rare contraindication to
stent graft treatment. However, 2 of the 4 patients that were
excluded from endovascular treatment on the basis of radiological
findings had a difference between proximal and distal arterial
diameters of more than 5 mm. They both presented with a chronic
arteriovenous fistula, respectively 7 and 10 years after injury, with
massively dilated proximal and small atrophic distal arteries. This
discrepancy was regarded as incompatible with successful endovas-
cular treatment and we were forced to treat them with open
surgery.
We thank Drs Smith and Carlson for focusing the attention on
these 2 issues.
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Regarding “Reference value of transcutaneous oxygen
measurement in diabetic patients compared with
nondiabetic patients”
We read with great interest the article of deMeijer et al1 about
the values of transcutaneous oxygen pressure (TcPO2) measure-
ments in diabetic compared with nondiabetic patients. The authors
found a 6-mm Hg difference in the mean chest and main foot
TcPO2 values between diabetic and nondiabetic subjects with
apparently no peripheral arterial disease. The authors suggest in
their conclusion that resting TcPO2 could be proposed as an
additional tool in the diagnostic armamentarium of vascular sur-
geons to assess peripheral vascular disease in diabetic patients.
First, there might be a lot of reasons (skin thickness, use of
vasoactive drugs) other than vascular disease that could modify
TcPO values. It is also not unlikely that the difference observed2
resulted from vascular dysfunction rather than from vascular dis-
